Key result
Measuring BNP to diagnose LVSD yields no quantitative results.
Why the study?
Does measuring brain natriuretic peptide effectively diagnose left ventricular systolic dysfunction in general practice patients?
Cross-Sectional
Does measuring brain natriuretic peptide effectively diagnose left ventricular systolic dysfunction in general practice patients?
Answers are grounded in this paper and cite their sources.
This study investigates the diagnostic utility of measuring brain natriuretic peptide for suspected left ventricular systolic dysfunction in a community setting.
The prevalence of heart failure is increasing. 1 Patients usually present to their general practitioner but a definitive diagnosis of left ventricular systolic dysfunction can only be achieved by cardiac imaging.Measuring plasma concentrations of brain natriuretic peptide has been advocated as a screening test that might reduce demands on cardiological services.2 We report the results of a community based study designed to investigate the effectiveness of measuring brain natriuretic peptide to diagnose left ventricular systolic dysfunction.The study was approved by the local research ethics committee.
No takes yet. Share an insight, caveat, or question.
Martin Landray (2000) conducted a cross-sectional in Suspected left ventricular systolic dysfunction. Measuring plasma concentrations of brain natriuretic peptide was evaluated on Diagnosis of left ventricular systolic dysfunction. Measuring brain natriuretic peptide was investigated for diagnosing left ventricular systolic dysfunction, but the abstract reports no quantitative results.
Synapse has enriched 10 related papers. Consider them for comparative context: